ArticleViruses2024

Cytomegalovirus-Specific Hyperimmune Immunoglobulin Administration for Secondary Prevention after First-Trimester Maternal Primary Infection: A 13-Year Single-Center Cohort Study.

Emmanouil Karofylakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.